Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder

This study has been completed.
Boehringer Ingelheim
Information provided by:
Eli Lilly and Company Identifier:
First received: July 20, 2005
Last updated: November 5, 2007
Last verified: November 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2005
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):